Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Lilly

Status and phase: Completed; Phase 3

Conditions: Urinary Stress Incontinence

Treatments: Drug: Duloxetine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00190853

F1J-MC-SBCT

9587

Details and patient eligibility

About

Biomechanical and electrophysiological effects of duloxetine in the treatment of women with urinary stress incontinence

Sex: Female

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have a diagnosis of only stress urinary incontinence
• Have no pelvic organ prolapse protruding more than 1 cm beyond the hymen

Exclusion criteria

• At visit 1, have a positive urine culture or a history of four or more urinary tract infections in the preceding year.
• Have had more than one continence surgery.
• Have a current or past urogenital cancer.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)